Latest News
US COVID-19 Hospitalizations Reach Record Low
Paxlovid Receives FDA Approval for COVID-19 Treatment
Minimally Invasive Surgical Off-Pump Ablation and Sinus Rhythm Restoration in AF
Vancomycin Plus Piperacillin-Tazobactam Increases AKI Risk in ICU Patients
AAPA 2023 Annual Award Winners Announced
How Do Diet and Physical Activity Affect Allergies?
Red-Flag Signs May Indicate Early-Onset Colorectal Cancer
Recent 2023 FDA Approvals
Opvee Nasal Spray Approved for Treatment of Opioid Overdose
Latest Features
What Do We Know About Post-COVID-19 Irritable Bowel Syndrome?
Some individuals hospitalized with COVID-19 later develop IBS. Drs Madhusudan Grover and Matthew Hoscheit weigh in on the GI dysfunction.
Chlamydia Infection: Silent Cause of Female Infertility
Studies link chlamydia to a high risk of female infertility. How should primary care providers assess for inflammation and tubal patency in affected patients?
Get Moving: Prescribing Exercise to End Insulin Resistance
Afternoon high intensity exercise may have a greater effect on lowering blood glucose levels in patients with diabetes than morning high intensity interval training.
Managing Anemia in Chronic Kidney Disease: Beyond Iron and ESAs
Iron therapy and erythropoiesis-stimulating agents are not always effective for anemia in patients with CKD. Nutritional interventions may be helpful in these cases.
NP Sued for Prescribing Too Much Medication to Patient
A nurse practitioner (NP) was sued after a patient was harmed because of a prescribing error.
NP/PA Practice Corner
New DEA Training Requirement Coming in June for Opioid Use Disorder
All DEA-registered clinicians must meet a one-time, 8-hour training requirement for opioid or other substance use disorder. Learn whether your past training meets the requirement.
Legislative Update: Colorado PA Bill Moves to Full Senate Review
Progress was made in SB 83 to allow Colorado PAs to move from supervision to collaboration agreements with physicians. Read about this and other NP and PA legislative updates.
CME/CE
Activity Type: Hosted
Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer | myCME
1.00 CME CE: Expert discussion on strategies for optimizing ICIs in advanced NSCLC including individualizing therapy and managing adverse events. Exp 12/26/23
Activity Type: Hosted
Dry Eye Disease Preservatives and First-Line Treatments | myCME
1.00 CME CE: Dry eye disease can worsen if not treated effectively. Novel formulations of tear replacement aim to treat without the deleterious effects of preservatives. Exp 4/28/24
More
- Loading...
Loading...
Loading... 
Loading...